Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 22, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the registrant.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction on December 21, 2006, where Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("the GSK Trust"), transferred 8,108 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The Company was advised of these transactions on December 22, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust where all employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the shares held in the GSK Trust in the same capacity as other employees.
Key Facts for Investor Verification
- Transaction Date: December 21, 2006.
- Shares Transferred: 8,108 Ordinary Shares.
- Recipient: Participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Trustee: Abacus (GSK) Trustees Limited.
- Directors with Interests: Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop.